Ascentage Pharma Group International SEC filings AAPG
Ascentage Pharma Group International has 132 filings in SEC EDGAR's recent list, going back to Jun 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Jan 24, 2025 | — |
| EFFECT | Filing | Jan 23, 2025 | — |
| CERT | Filing | Jan 23, 2025 | — |
| 8-A12B | Filing | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| SEC STAFF LETTER | Filing | Dec 17, 2024 | — |
| DRS/A | Filing | Dec 10, 2024 | — |
| DRS/A | Filing | Sep 16, 2024 | — |
| DRSLTR | Filing | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| DRSLTR | Filing | Aug 27, 2024 | — |
| DRS/A | Filing | Aug 27, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| DRSLTR | Filing | Jul 31, 2024 | — |
| DRS/A | Filing | Jul 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2024 | — |
| DRS | Filing | Jun 14, 2024 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AAPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Suzhou , Jiangsu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2023311
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.